HYUNDAI BIOLAND Statistics

Total Valuation

HYUNDAI BIOLAND has a market cap or net worth of KRW 126.30 billion. The enterprise value is 135.21 billion.

Market Cap	126.30B
Enterprise Value	135.21B

Important Dates

The last earnings date was Wednesday, March 12, 2025.

Earnings Date	Mar 12, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

HYUNDAI BIOLAND has 30.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	30.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	1.72%
Float	19.50M

Valuation Ratios

The trailing PE ratio is 10.26 and the forward PE ratio is 7.43.

PE Ratio	10.26
Forward PE	7.43
PS Ratio	1.06
PB Ratio	0.92
P/TBV Ratio	0.93
P/FCF Ratio	131.92
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.92, with an EV/FCF ratio of 141.23.

EV / Earnings	23.71
EV / Sales	1.13
EV / EBITDA	5.92
EV / EBIT	8.28
EV / FCF	141.23

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.26.

Current Ratio	1.79
Quick Ratio	0.71
Debt / Equity	0.26
Debt / EBITDA	1.55
Debt / FCF	36.99
Interest Coverage	32.55

Financial Efficiency

Return on equity (ROE) is 8.99% and return on invested capital (ROIC) is 5.96%.

Return on Equity (ROE)	8.99%
Return on Assets (ROA)	5.39%
Return on Invested Capital (ROIC)	5.96%
Return on Capital Employed (ROCE)	11.75%
Revenue Per Employee	373.50M
Profits Per Employee	17.82M
Employee Count	320
Asset Turnover	0.63
Inventory Turnover	1.35

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.35% in the last 52 weeks. The beta is 0.70, so HYUNDAI BIOLAND's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	-51.35%
50-Day Moving Average	4,627.40
200-Day Moving Average	4,931.83
Relative Strength Index (RSI)	31.71
Average Volume (20 Days)	67,445

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HYUNDAI BIOLAND had revenue of KRW 119.52 billion and earned 5.70 billion in profits. Earnings per share was 190.10.

Revenue	119.52B
Gross Profit	52.69B
Operating Income	16.33B
Pretax Income	15.88B
Net Income	5.70B
EBITDA	22.84B
EBIT	16.33B
Earnings Per Share (EPS)	190.10

Full Income Statement

Balance Sheet

The company has 26.50 billion in cash and 35.41 billion in debt, giving a net cash position of -8.91 billion or -296.98 per share.

Cash & Cash Equivalents	26.50B
Total Debt	35.41B
Net Cash	-8.91B
Net Cash Per Share	-296.98
Equity (Book Value)	138.01B
Book Value Per Share	4,600.28
Working Capital	44.16B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.60 billion and capital expenditures -3.64 billion, giving a free cash flow of 957.38 million.

Operating Cash Flow	4.60B
Capital Expenditures	-3.64B
Free Cash Flow	957.38M
FCF Per Share	31.91

Full Cash Flow Statement

Margins

Gross margin is 44.08%, with operating and profit margins of 13.66% and 4.77%.

Gross Margin	44.08%
Operating Margin	13.66%
Pretax Margin	13.29%
Profit Margin	4.77%
EBITDA Margin	19.11%
EBIT Margin	13.66%
FCF Margin	0.80%

Dividends & Yields

This stock pays an annual dividend of 35.00, which amounts to a dividend yield of 0.83%.

Dividend Per Share	35.00
Dividend Yield	0.83%
Dividend Growth (YoY)	100.00%
Years of Dividend Growth	1
Payout Ratio	18.41%
Buyback Yield	n/a
Shareholder Yield	0.83%
Earnings Yield	4.52%
FCF Yield	0.76%

Dividend Details

Stock Splits

The last stock split was on May 17, 2024. It was a forward split with a ratio of 2.

Last Split Date	May 17, 2024
Split Type	Forward
Split Ratio	2

Scores

HYUNDAI BIOLAND has an Altman Z-Score of 3.56.

Altman Z-Score	3.56
Piotroski F-Score	n/a